Clinical trials

Last Update -- November 2, 2007   (updated monthly)

ClinicalTrials.gov

From ClinicalTrials.gov "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk Condition: Prostate Cancer Hormone Therapy With or Without Mitoxantrone and Prednisone in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer Conditions: adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; ... Hormone Therapy in Treating Men With Stage IV Prostate Cancer Conditions: adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer Conditions: adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate Condition: Prostate Cancer Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients with Locally Advanced Prostate Cancer Conditions: adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated with One Cytotoxic Chemotherapy Regimen Conditions: Prostate Cancer; Hormone Refractory Prostate Cancer; One Prior Cytotoxic Chemotherapy Regimen Surgery in Treating Patients With Prostate Cancer Condition: recurrent prostate cancer APC8015 (Provenge®) in Treating Patients With Asymptomatic Metastatic Androgen-Independent Prostate Cancer Conditions: adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer Provenge® Immunotherapy Vaccine for the Treatment of Metastatic Prostate Cancer after Failing Hormone Therapy Condition: Prostate Cancer Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer Conditions: adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer Conditions: adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer Selenium and Vitamin E Cancer Prevention Trial (SELECT) Condition: Prostate Cancer Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer Conditions: adenocarcinoma of the prostate; stage III prostate cancer Epoetin alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer Conditions: recurrent prostate cancer; Anemia; Fatigue Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction Condition: Cancer AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer Condition: Prostate Cancer Radiolabeled Monoclonal Antibody in Treating Patients With Progressive Metastatic Androgen-Independent Adenocarcinoma (Cancer) of the Prostate Conditions: adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer Conditions: adenocarcinoma of the prostate; recurrent prostate cancer Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-sparing Prostatectomy Conditions: Impotence; Prostate Cancer PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer after Failing Hormone Therapy Condition: Prostate Cancer MEDI-522 in the Treatment of Patients with Metastatic Androgen-Independent Prostate Cancer Condition: Prostate Cancer Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer Conditions: adenocarcinoma of the prostate; stage II prostate cancer; stage I prostate cancer Evaluate Risk Factors which Predict the Transformation of Early Stage to Clinically Aggressive Prostate Cancer Condition: Prostate Cancer Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Antigen Levels Condition: Prostate Cancer CT Scans in Guiding the Treatment of Patients With Prostate Cancer Who are Undergoing Radiation Therapy Conditions: stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer Conditions: adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer Conditions: Breast Cancer; Colorectal Cancer; Lung Cancer; Prostate Cancer Vaccine Therapy in Treating Patients With Gastric Cancer, Non-Small Cell Lung Cancer, Prostate, or Ovarian Cancer Conditions: adult brain tumor; Gastric Cancer; Non-small cell lung cancer; ovarian epithelial cancer; Prostate Cancer Study of ILX651 in Patients with Hormone-Refractory Prostate Cancer Previously Treated with Docetaxel Condition: Hormone-Refractory Prostate Cancer Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008 Conditions: adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer; bone metastases Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases Conditions: adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer; bone metastases Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Conditions: adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer; bone metastases Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate Conditions: adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer MLN2704 in Treating Patients With Progressive Metastatic Prostate Cancer Conditions: adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer Rapid Hormone Cycling With Testosterone and Leuprolide Combined With Docetaxel in Treating Patients With Recurrent or Metastatic Adenocarcinoma (Cancer) of the Prostate Conditions: adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer MLN2704 in Treating Patients With Progressive Metastatic Prostate Cancer Conditions: adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer Conditions: adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate Cancer Conditions: adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer Doxercalciferol Before Surgery in Treating Localized Prostate Cancer Conditions: adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer Conditions: adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer PET Scan in Treating Patients With Metastatic Prostate Cancer Conditions: adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer Conditions: adult glioblastoma; recurrent prostate cancer; recurrent adult brain tumor; stage IV prostate cancer; adult giant cell glioblastoma; ... Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors Conditions: unspecified adult solid tumor, protocol specific; stage IV prostate cancer; recurrent prostate cancer Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases Conditions: recurrent prostate cancer; stage IV prostate cancer; bone metastases Zoledronate and Estradiol in Preventing Bone Loss in Patients With Prostate Cancer Conditions: Osteoporosis; stage III prostate cancer; stage IV prostate cancer Group Therapy Compared With Educational Materials in Patients With Prostate Cancer Conditions: stage I prostate cancer; stage II prostate cancer; psychosocial effects/treatment; Quality of Life Study of Individualized Amonafide to Treat Prostate Cancer Condition: Prostate Cancer A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy Condition: Prostate Cancer Phase 1 Single Ascending Dose Trial of MLN2704 in Subjects with Metastatic Androgen Independent Prostate Cancer Condition: Prostate Cancer Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer Conditions: adenocarcinoma of the prostate; stage III prostate cancer; Quality of Life Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy Conditions: adenocarcinoma of the prostate; recurrent prostate cancer Computer Planned Radiation Therapy in Treating Patients With Prostate Cancer Conditions: adenocarcinoma of the prostate; stage II prostate cancer Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer Condition: Cancer 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors Condition: Cancer Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma Condition: Cancer Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma Condition: Cancer MLN2704 in Subjects with Metastatic Androgen-Independent Prostate Cancer Condition: Prostatic Neoplasms Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors Conditions: Breast Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms; Lung Neoplasms Safety and pharmacokinetics of orally administered gallium maltolate in various refractory malignancies. Conditions: Prostatic Neoplasms; Multiple Myeloma; Bladder Neoplasms; Lymphoma Phase II Trial of Monoclonal Antibody (J591) in Combination with Low-Dose Subcutaneous Interleukin-2 Condition: Prostatic Neoplasms